Physician profile

Amy Kleinhans

Adult Health (Nurse Practitioner) · Mesa, AZ

NPI 1821441718

$59,981.74

in general payments reported to CMS, 2019-2025

31 companies · $14K in 2025

The $14K reported for 2025 was more than what 99% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).

See the full distribution for Adult Health (Nurse Practitioner)

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$21,053.46
Consulting Fee$6,475.00
Travel and Lodging$5,273.71
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$4,800.00
Honoraria$3,350.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Boston Scientific Corporation $13,107.01 2021-2025 Watchman Access System, Watchman Flx, Farapulse
Cvrx, INC. $12,567.08 2021-2025 Barostim Neo System
Abbott Laboratories $12,043.11 2021-2025 Aveir, Cardiomems, Ensite
Impulse Dynamics (USA) INC. $8,099.22 2021-2024 Optimizer, Optimizer
Atricure, INC. $2,230.64 2021-2025 Epi-Sense Guided Coagulation System With Visitrax
Biosense Webster, INC. $1,688.35 2023-2025 Carto 3
Kestra Medical Technology Services, INC. $1,637.56 2022-2025 Assure Wcd
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $1,623.14 2021-2025 Lifevest
Cardiva Medical, INC. $1,512.00 2021-2025 Cardiva Vascade Mvp Vvcs 6-12f
Philips North America LLC $954.20 2022-2025 (Am5) Lead Management, (Ck4) Mcot, Ecc Solutions
Zoll Respicardia, INC. $773.75 2021-2024 Remede System
Medtronic, INC. $653.02 2021-2025 Na, Micra, Pulseselect
Ebr Systems, INC. $526.55 2025
Inspire Medical Systems, INC. $320.62 2021
Synaptic Medical Corporation $312.13 2025
Show all 31 companies
CompanyGeneral paymentsYearsTop products
Sanofi-Aventis U.S. LLC $245.17 2022-2024
Itamar Medical INC $242.01 2022-2023 Watchpatone
Altathera Pharmaceuticals LLC $162.29 2021-2022
Edwards Lifesciences Corporation $145.72 2023 Edwards Sapien 3 Transcatheter Heart Valve (Thv)
Biotronik INC. $139.21 2022-2023 Renamic Neo
Astrazeneca Pharmaceuticals LP $125.00 2021
Actelion Pharmaceuticals US, INC. $121.82 2023 Uptravi, Opsumit
Alnylam Pharmaceuticals INC. $114.83 2023 Onpattro
Novartis Pharmaceuticals Corporation $111.15 2023
Boehringer Ingelheim Pharmaceuticals, INC. $110.57 2021
Janssen Pharmaceuticals, INC $98.73 2021-2022
Heartflow, INC. $95.02 2022
Preventice Services, LLC $82.80 2021
Baxter Healthcare $79.37 2024 Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor
Pfizer INC. $44.67 2022
Bardy Diagnostics, INC. $15.00 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Amy Kleinhans

$59,981.74

in general payments reported 2019-2025

Years
2021-2025
Top company
Boston Scientific Corporation
Context
The $14K reported for 2025 was more than what 99% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).

https://glasscript.com/doctor/10752474/amy-kleinhans

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.